Tech Company Financing Transactions
OpenEvidence Funding Round
DST Global, Thrive Capital and Alkeon Capital participated in a $250 million Series D funding round for OpenEvidence. The financing round was announced on 1/21/2026.
Transaction Overview
Company Name
Announced On
1/21/2026
Transaction Type
Venture Equity
Amount
$250,000,000
Round
Series D
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
Undisclosed
Cambridge, MA Undisclosed
USA
Cambridge, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
OpenEvidence is the leading medical information platform. Our mission is to organize and expand the world's collective medical knowledge. OpenEvidence is what we always imagined when we used to talk about someone finally solving medical search.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Nadler
Browse more venture capital transactions:
Prev: 1/21/2026: L-Nutra venture capital transaction
Next: 1/21/2026: Infinitopes venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to record funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs